<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827511</url>
  </required_header>
  <id_info>
    <org_study_id>142312202069</org_study_id>
    <nct_id>NCT04827511</nct_id>
  </id_info>
  <brief_title>Refractive Disorders and Seric Vitamin D Level in Children With Disabilities</brief_title>
  <acronym>REDIC</acronym>
  <official_title>Refractive Disorders and Seric Vitamin D Level in Children With Disabilities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Holhos Larisa Bianca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Elisantes Teola SRL</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator want to determine the refractive status of 80 children with disabilities and&#xD;
      of 81 healthy children from a witness group. The vitamin D level of the children will be&#xD;
      dosed for making different correlations with visual acuity status.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Refraction measurement will be done by the investigator in all 161 children. Visual acuity is&#xD;
      checked, initial and after correction with proper correction. Vitamin D level is dosed from&#xD;
      all the children in order to make correlations with the visual acuity, refractive status and&#xD;
      risk for visual impairment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>19 Months</target_duration>
  <primary_outcome>
    <measure>Refractive disorders in children with disabilities</measure>
    <time_frame>1 January 2019-31 August 2020</time_frame>
    <description>Prevalence of refractive disorders in children with disabilities</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">161</enrollment>
  <condition>Child, Only</condition>
  <arm_group>
    <arm_group_label>cohort group</arm_group_label>
    <description>80 children with disabilities like autism, ADHD, Down syndrome, deafness, phocomelia, dyslexia, different motor problems</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>81 healthy children, not known or diagnosed with a chronic disease of any kind</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Refraction measurement with auto-ref-keratometer Canon</intervention_name>
    <description>Refractive measurement and vitamin D level dosing</description>
    <arm_group_label>cohort group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        80 children with disabilities like ADHD, autism, Down syndrome, deafness, phocomelia and 81&#xD;
        clinically healthy children&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children with disabilities and healthy children&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children diagnosed with another chronic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holhoș L Bianca, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine and Pharmacy Oradea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Holhoș Larisa Bianca</name>
      <address>
        <city>Marghita</city>
        <state>Bihor</state>
        <zip>415300</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Elisantes Teola SRL</investigator_affiliation>
    <investigator_full_name>Holhos Larisa Bianca</investigator_full_name>
    <investigator_title>Specialist in Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>disability, healthy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Reports from the statistical analysis</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>20/10/2021-20/10/2031</ipd_time_frame>
    <ipd_access_criteria>by invitation</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

